C-Path (Critical Path TRXA-Therapeutic accelerator)

Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has announced its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants (BRIDGe). These BRIDGe awards are designed to support academic researchers in delving into drug development approaches and defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to… Read more »